Sticky cell breakthrough offers new hope for liver repair without transplants
HQ Team October 30, 2025: For millions of people with severe liver disease, a transplant is the only hope. Now a new discovery
Health
Research
Drugs
Research
New potent antibiotic discovery offers new hope in fight against superbugs
HQ Team October 30, 2025: Research teams from the University of Warwick and Monash University Chemists have discovered a promising new antibiotic that
Health
Research
Ultra-processed food addiction, an overlooked health crisis among older adults
A surprising 12% of older Americans are addicted to ultra-processed foods—a rate that surpasses alcohol or tobacco addiction in this age group. For
Drugs
Health
HIV’s shape-shifting protein reveals clues for smarter drug design
A study from the Salk Institute has found HIV’s ability to hijack human cells, uncovering a shape-shifting viral protein that could transform treatments for the
Drugs
Health
Pharma
AstraZeneca, Amgen’s drug for nasal inflammation gets EU nod
The European Union approved AstraZeneca Plc and Amgen Inc.’s add-on therapy to treat adults with a chronic inflammatory condition of the nasal passages.
Drugs
Health
Pharma
China’s Innovent, Japan’s Takeda in $11.4 billion deal for cancer therapies
China’s Innovent Biologics and Takeda Pharmaceutical Co. announced a $11.4 billion licensing deal, which will enable the former to speed up the development
Drugs
Health
Pharma
Asset managers Blackstone, TGP to acquire Hologic for $18.3 billion
Hologic Inc., which specialises in women’s health diagnostics, is set to be acquired in a deal worth $18.3 billion backed by asset managers
Drugs
Health
Pharma
US regulator clears Glaukos Corp.’s drug to treat rare eye condition
The Food and Drug Administration has approved Glaukos Corporation’s drug to treat keratoconus, a rare, sight-threatening eye disease that is currently far too
Drugs
Health
Pharma
Merck to spend $70 billion to expand domestic manufacturing in US
Merck and Co. will invest up to $70 billion to expand its domestic manufacturing in the US after President Donald Trump urged pharmaceutical
Drugs
Health
Pharma
Novo to buy Akero for $5.2 billion, to pocket trial liver disease drug
Novo Nordisk will acquire US-based Akero Therapeutics, Inc. for $5.2 billion to pocket an experimental drug in end-stage trials to treat liver disease,